3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gastrointestinal
1
Conditions
Urinary Incontinence
1
Sexual Dysfunction, Physiological
1
Rectal Neoplasms
1
Interventions
Capecitabine
8
Fluorouracil
6
Radiotherapy
5
Leucovorin
5
Oxaliplatin
4
Laparoscopy
4
XELOX
3
Cetuximab
3
Irinotecan
2
Folfox protocol
2
Drug Therapy
2
Chemoradiotherapy
2
selinexor
1
citric acid, ispaghula husk, sodium bicarbonate drug combination
1
capecitabine-irinotecan combination
1
Vitamin D Response Element
1
Vi-siblin
1
Transanal Endoscopic Microsurgery
1
Robotics
1
Robotic Surgical Procedures
1
Psyllium
1
Polyethylene Glycols
1
N-hydroxy-4-acetylaminostilbene
1
Metronidazole
1
Mastectomy, Segmental
1
Liver Extracts
1
Immunohistochemistry
1
Frozen Sections
1
Fluorescein Angiography
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Rectal Neoplasms
×
Robotics
×
Clear all
NCT03209076
2019-10-16
RAR
Instituto Nacional de Cancer, Brazil
Phase NA
Unknown
120 enrolled